AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug…
Reality of Trump’s drug pricing to set in over next 18 months
Vas Narasimhan, chief executive officer of Novartis AG, during an announcement in the Roosevelt Room of the White…
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
UK, China rush to forge business deals
China’s President Xi Jinping (R) and Britain’s Prime Minister Keir Starmer shake hands before their meeting at the…
How global CEOs are shifting gears
Trade tensions are rising, forcing top executives to rewrite the rulebook on how their companies operate, where they invest…
‘The era of quantum supremacy is just around the corner,’ IonQ CEO says
IonQ CEO Niccolo de Masi told CNBC’s Jim Cramer on Thursday that major advances in quantum computing are…